0001562180-15-000223.txt : 20150327
0001562180-15-000223.hdr.sgml : 20150327
20150327112226
ACCESSION NUMBER: 0001562180-15-000223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150325
FILED AS OF DATE: 20150327
DATE AS OF CHANGE: 20150327
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kanes Stephen
CENTRAL INDEX KEY: 0001612859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 15729541
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-03-25
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001612859
Kanes Stephen
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Medical Officer
Common Stock
2015-03-25
4
S
false
5400.00
51.49
D
46948.00
D
This transaction was executed in multiple trades at prices ranging from $51.38 USD to $51.645 USD. The price reported above reflects the weighted average sale price.
/s/ Stephen Kanes
2015-03-26